Free Trial

Guardant Health (GH) Short Interest Ratio & Short Volume

$27.10
-0.37 (-1.35%)
(As of 05/31/2024 ET)

Guardant Health Short Interest Data

Current Short Interest
10,760,000 shares
Previous Short Interest
10,160,000 shares
Change Vs. Previous Month
+5.91%
Dollar Volume Sold Short
$277.07 million
Short Interest Ratio
4.7 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
122,370,000 shares
Percentage of Shares Shorted
8.79%
Today's Trading Volume
3,615,994 shares
Average Trading Volume
2,626,418 shares
Today's Volume Vs. Average
138%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Guardant Health ?

Sign up to receive the latest short interest report for Guardant Health and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GH Short Interest Over Time

GH Days to Cover Over Time

GH Percentage of Float Shorted Over Time

Guardant Health Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/202410,760,000 shares $277.07 million +5.9%N/A4.7 $25.75
4/30/202410,160,000 shares $182.88 million +6.3%N/A5.3 $18.00
4/15/20249,560,000 shares $163.09 million +25.1%N/A4.8 $17.06
3/31/20247,640,000 shares $157.61 million -1.6%N/A4 $20.63
3/15/20247,760,000 shares $137.66 million +10.1%N/A4.8 $17.74
2/29/20247,050,000 shares $133.95 million +24.1%N/A4.3 $19.00
2/15/20245,680,000 shares $125.70 million +2.5%N/A3.6 $22.13
1/31/20245,540,000 shares $121.49 million +4.1%N/A3.5 $21.93
1/15/20245,320,000 shares $128.74 million +1.7%N/A3.2 $24.20
12/31/20235,230,000 shares $141.47 million -4.7%N/A3.3 $27.05
12/15/20235,490,000 shares $154.76 million -4.4%N/A3.3 $28.19
11/30/20235,740,000 shares $144.48 million -9.5%N/A3.4 $25.17
11/15/20236,340,000 shares $144.68 million -9.4%N/A3.5 $22.82
10/31/20237,000,000 shares $181.16 million -5.0%N/A4.2 $25.88
10/15/20237,370,000 shares $199.21 million +5.1%N/A4.6 $27.03
9/30/20237,010,000 shares $207.78 million +1.5%N/A4.5 $29.64
9/15/20236,910,000 shares $204.05 million -1.4%N/A4.5 $29.53
8/31/20237,010,000 shares $273.95 million +2.5%N/A4 $39.08
8/15/20236,840,000 shares $242.07 million -8.2%N/A3.4 $35.39
7/31/20237,450,000 shares $290.70 million -9.3%N/A3.4 $39.02
7/15/20238,210,000 shares $314.61 million -4.8%N/A3.8 $38.32
6/30/20238,620,000 shares $308.60 million +13.1%N/A4 $35.80
6/15/20237,620,000 shares $288.49 million +10.0%N/A3.5 $37.86
5/31/20236,930,000 shares $203.19 million -2.4%N/A3.4 $29.32
5/15/20237,100,000 shares $198.02 million +11.1%7.3%3.5 $27.89
4/30/20236,390,000 shares $144.16 million -8.6%6.5%3.3 $22.56
4/15/20236,990,000 shares $171.26 million +3.4%7.2%3.7 $24.50
3/31/20236,760,000 shares $158.45 million +7.1%6.9%3.4 $23.44
3/15/20236,310,000 shares $168.98 million -9.9%6.5%3.1 $26.78
2/28/20237,000,000 shares $216.23 million +13.1%7.2%3.4 $30.89
2/15/20236,190,000 shares $179.32 million +11.9%6.3%3.2 $28.97
1/31/20235,530,000 shares $173.81 million -0.4%6.1%3.3 $31.43
1/15/20235,550,000 shares $168.89 million +8.8%5.7%3.5 $30.43
12/30/20225,100,000 shares $138.72 million +18.9%5.3%3.3 $27.20
12/15/20224,290,000 shares $177.01 million +3.9%4.4%3.1 $41.26
11/30/20224,130,000 shares $216.16 million -1.9%4.3%4.1 $52.34
11/15/20224,210,000 shares $215.76 million +5.5%4.4%4.1 $51.25
10/31/20223,990,000 shares $197.51 million +1.8%4.1%4 $49.50
10/15/20223,920,000 shares $191.14 million +4.3%4.1%4 $48.76
9/30/20223,760,000 shares $202.40 million -12.2%3.9%4.1 $53.83
The #1 Crypto That You Don’t Own… Yet (Ad)

There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.

Click here for all the details…
9/15/20224,280,000 shares $252.05 million -7.2%4.5%4.6 $58.89
8/31/20224,610,000 shares $230.78 million +3.1%4.8%4.5 $50.06
8/15/20224,470,000 shares $246.03 million +5.9%4.6%4 $55.04
7/31/20224,220,000 shares $211.72 million +7.9%4.4%2.9 $50.17
7/15/20223,910,000 shares $190.46 million -2.3%4.1%2.6 $48.71
6/30/20224,000,000 shares $161.36 million -7.2%4.2%2.8 $40.34
6/15/20224,310,000 shares $165.59 million +7.5%4.5%3 $38.42
5/31/20224,010,000 shares $164.33 million +16.2%4.2%2.9 $40.98
5/15/20223,450,000 shares $123.89 million -11.8%3.6%2.5 $35.91
4/30/20223,910,000 shares $241.25 million +3.2%4.1%3.5 $61.70
4/15/20223,790,000 shares $272.84 million +0.8%4.0%3.6 $71.99
3/31/20223,760,000 shares $249.06 million -1.1%N/A0 $66.24
3/15/20223,800,000 shares $185.29 million -1.8%4.0%3.3 $48.76
2/28/20223,870,000 shares $256.46 million +13.2%4.1%3.3 $66.27
2/15/20223,420,000 shares $247.54 million -15.6%3.6%2.8 $72.38
1/31/20224,050,000 shares $281.68 million -4.5%4.3%3.3 $69.55
1/15/20224,240,000 shares $328.94 million +0.7%N/A3.6 $77.58
12/31/20214,210,000 shares $421.08 million -12.3%4.4%4 $100.02
12/15/20214,800,000 shares $463.39 million +11.4%5.1%4.3 $96.54
11/30/20214,310,000 shares $453.07 million +8.8%4.5%4.2 $105.12
11/15/20213,960,000 shares $410.45 million +5.9%4.2%4 $103.65
10/29/20213,740,000 shares $436.79 million -13.0%3.9%4.1 $116.79
10/15/20214,300,000 shares $436.88 million -7.1%4.5%4.7 $101.60
9/30/20214,630,000 shares $578.80 million +7.2%4.9%5.2 $125.01
9/15/20214,320,000 shares $548.64 million +3.4%4.6%5.5 $127.00
8/31/20214,180,000 shares $531.99 million +9.7%4.4%4.8 $127.27
8/13/20213,810,000 shares $385.88 million +16.2%4.0%4.3 $101.28
7/30/20213,280,000 shares $360.14 million -4.4%3.4%3.4 $109.80
7/15/20213,430,000 shares $389.72 million -12.7%3.6%3.6 $113.62
6/30/20213,930,000 shares $488.07 million +3.7%4.1%4 $124.19
6/15/20213,790,000 shares $446.05 million -4.8%4.2%3.9 $117.69
5/28/20213,980,000 shares $494.00 million -5.2%4.4%4.3 $124.12
5/14/20214,200,000 shares $461.03 million +1.0%4.7%4.2 $109.77
4/30/20214,160,000 shares $668.51 million -16.5%4.6%4.2 $160.70
4/15/20214,980,000 shares $772.05 million +0.6%N/A0 $155.03
3/31/20214,950,000 shares $726.61 million -0.6%5.6%4.7 $146.79
3/15/20214,980,000 shares $711.94 million +29.7%5.6%4.6 $142.96
2/26/20213,840,000 shares $573.89 million +3.5%4.3%3.4 $149.45
2/12/20213,710,000 shares $624.43 million +11.4%4.2%3.7 $168.31
1/29/20213,330,000 shares $521.74 million -17.0%3.9%3.1 $156.68
1/15/20214,010,000 shares $630.65 million +7.5%4.7%3.9 $157.27
12/31/20203,730,000 shares $470.50 million +13.0%4.4%3.6 $126.14
12/15/20203,300,000 shares $402.53 million +4.4%3.8%3.3 $121.98
11/30/20203,160,000 shares $374.97 million +66.3%3.7%3.1 $118.66
11/15/20201,900,000 shares $220.70 million -8.7%2.2%1.9 $116.16
10/30/20202,080,000 shares $228.13 million -2.8%2.4%2.3 $109.68
10/15/20202,140,000 shares $227.42 million -8.9%2.5%2.3 $106.27
9/30/20202,350,000 shares $262.68 million +6.3%3.0%2.6 $111.78
9/15/20202,210,000 shares $227.85 million -12.3%2.8%2.6 $103.10
8/31/20202,520,000 shares $240.66 million -4.6%3.3%3.1 $95.50
The #1 Crypto That You Don’t Own… Yet (Ad)

There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.

Click here for all the details…
8/14/20202,640,000 shares $225.61 million -1.1%3.5%2.6 $85.46
7/31/20202,670,000 shares $227.43 million -5.3%3.5%2.6 $85.18
7/15/20202,820,000 shares $234.68 million -14.6%3.9%2.7 $83.22
6/30/20203,300,000 shares $267.73 million +39.2%4.7%3.1 $81.13
6/15/20202,370,000 shares $192.11 million +4.0%3.4%2.3 $81.06
5/29/20202,280,000 shares $206.09 million -1.7%3.6%2 $90.39
5/15/20202,320,000 shares $226.20 million -23.2%3.8%1.9 $97.50
4/30/20203,020,000 shares $232.42 million -12.7%3.7%2.4 $76.96
4/15/20203,460,000 shares $233.48 million +3.9%6.4%2.9 $67.48
3/31/20203,330,000 shares $253.71 million -19.5%6.2%2.7 $76.19
3/13/20204,136,700 shares $284.89 million -10.3%7.7%2.3 $68.87
2/28/20204,610,000 shares $276.23 million +41.4%8.6%4 $59.92
2/14/20203,260,000 shares $221.19 million +6.5%6.1%3.4 $67.85
1/31/20203,060,000 shares $249.39 million -12.8%5.8%3.4 $81.50
1/15/20203,510,000 shares $276.10 million -8.1%7.0%3.7 $78.66
12/31/20193,820,000 shares $305.75 million -1.6%7.6%4 $80.04
8/15/20192,891,700 shares $272.86 million -13.2%10.0%2.7 $94.36

GH Short Interest - Frequently Asked Questions

What is Guardant Health's current short interest?

Short interest is the volume of Guardant Health shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 10,760,000 shares of GH short. Learn More on Guardant Health's current short interest.

What is a good short interest ratio for Guardant Health?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GH shares currently have a short interest ratio of 5.0. Learn More on Guardant Health's short interest ratio.

Which institutional investors are shorting Guardant Health?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Guardant Health: Walleye Trading LLC, Jane Street Group LLC, Torno Capital LLC, and Nomura Holdings Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Guardant Health's short interest increasing or decreasing?

Guardant Health saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 10,760,000 shares, an increase of 5.9% from the previous total of 10,160,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Guardant Health's short interest compare to its competitors?

Here is how the short interest of companies compare to Guardant Health: Genetron Holdings Limited (0.08%), Exact Sciences Co. (4.61%), RadNet, Inc. (4.25%), Fortrea Holdings Inc. (6.36%), Veracyte, Inc. (5.86%), CareDx, Inc (11.55%), Viridian Therapeutics, Inc. (15.36%), Castle Biosciences, Inc. (4.67%), Fulgent Genetics, Inc. (3.65%), Celcuity Inc. (6.02%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Guardant Health stock?

Short selling GH is an investing strategy that aims to generate trading profit from Guardant Health as its price is falling. GH shares are trading down $0.37 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Guardant Health?

A short squeeze for Guardant Health occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GH, which in turn drives the price of the stock up even further.

How often is Guardant Health's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GH, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:GH) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners